FDA Investigator

Jasmine Y Wang

Latest inspection on record: Los Angeles, United States, May 2026 · records back to 2023

Human DrugsMedical Devices & Rad HealthBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 48 inspections across 47 sites are on record.
  • 33 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-13.

At a glance

Inspections

48

Sites

47

Observations

33

Career since

Apr 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Doris V. Quon, M.D.13 May 2026Biologics
Sargon Lazarof, DDS1 May 2026Medical Devices & Rad HealthOn file
Jonathan W. Goldman, MD9 Apr 2026Human Drugs
Paul W. Wallace, MD17 Mar 2026Human DrugsOn file
Nicholas McAndrew M.D.6 Feb 2026Human Drugs

Sites inspected

Doris V. Quon, M.D.Los Angeles, United States1 insp.
Sargon Lazarof, DDSEncino, United States1 insp.
Jonathan W. Goldman, MDSanta Monica, United States1 insp.
Paul W. Wallace, MDLos Angeles, United States1 insp.
Nicholas McAndrew M.D.Santa Monica, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Jose A Leyva6 shared
Korina Serrano2 shared
Cheron M Portee2 shared
Bruno Baltazar1 shared
Michelle S Anantha1 shared

Full investigator report

Get the verbatim findings behind Jasmine Y Wang's 33 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators